Zelgen Biopharmaceuticals
Pharmaceutical company developing targeted small-molecule therapies for cancer and hematologic disease.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Small-cell Lung Cancer
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung CancerPhase 1 · Recruiting · Small Cell Lung Cancer
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.Phase 1 · Recruiting · Neuroendocrine Carcinoma
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular CarcinomaPhase 2 · Recruiting · Hepatocellular Carcinoma
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine CarcinomaPhase 1 · Recruiting · Small Cell Lung Cancer
Study of ZGGS18 in Patients With Advanced Solid TumorsPhase 1 · Recruiting · Advanced Solid Tumor
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/zelgen-biopharmaceuticals/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.